Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Sage Therapeutics said on Monday that its board has unanimously rejected Biogen’s $469 million offer, stating it ...

Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen. The ...

Amalia Holguin, Addison Uphoff and Kamdyn Klamberg combine for 47 points as Sage Hill wins its sixth straight game.

Sage Group PLC SGE shares inched down 0.49% to £13.30 Friday, on what proved to be an all-around poor trading session for the ...

Sage Group PLC SGE shares inched up 0.26% to £13.37 Thursday, on what proved to be an all-around great trading session for ...

Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the ...

Throughout Mark Harmon’s run on the first 19 seasons of NCIS, the show would occasionally throw out a Gibbs Rule. Those are ...

Sage Therapeutics rejected a takeover offer from Biogen ( BIIB) and said it started a process to review its strategic ...

Sage Therapeutics has a unique approach to targeting GABA, which allows it to target CNS disorders. Read why I think SAGE ...

Investing.com -- Sage Therapeutics, Inc. (NASDAQ: SAGE) stock climbed 2.5% today, reflecting investor sentiment after the company announced the initiation of a strategic review process and the ...

Sage Therapeutics Inc. rejected a takeover offer from drugmaker Biogen Inc. and said it has started exploring possible options including a sale.